Navigation Links
Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology

ion from 2:00 p.m. to 6:00 p.m. local time on

Sunday, June 1, 2008.

-- "Dose effect of ipilimumab in patients with advanced melanoma: results

from a phase 2, randomized, dose-ranging study" (Abstract #9025,

Melanoma Session) -- Poster presentation and discussion from 2:00 p.m.

to 6:00 p.m. local time on Sunday, June 1, 2008.

-- "Prolonged survival in objective responders to ipilimumab therapy"

(Abstract #20004) -- Publication only.

Response and Safety Data of Ipilimumab in Prostate

-- "Phase 1 trial of ipilimumab (IPI) alone and in combination with

radiotherapy (XRT) in patients with metastatic castration resistant

prostate cancer (mCRPC)" (Abstract #5004, New Targeted Strategies for

Patients with Prostate Cancer Session) -- Oral presentation beginning

at 11:30 a.m. local time on Monday, June 2, 2008.

-- "Expanded phase 1 combination trial of GVAX immunotherapy for prostate

cancer and ipilimumab in patients with metastatic hormone-refractory

prostate cancer (mHRPC)" (Abstract #5146, Genitourinary Cancer Session)

-- Poster presentation from 8:00 a.m. to 12:00 p.m. local time on

Saturday, May 31, 2008.

Clinical and Preclinical Data of Additional Immunotherapy and Antibody-Drug Conjugate Programs

-- "Safety and activity of MDX-1106 (ONO-4538), an anti-PD-1 monoclonal

antibody, in patients with selected refractory or relapse malignancies"

(Abstract #3006, Developmental Therapeutics: Immunotherapy

Session) -- Oral presentation beginning at 4:00 p.m. local time on

Saturday, May 31, 2008.

-- "Antitumor activity of anti-CTLA-4 monoclonal antibody (mAb) in

combination with ixabepilone in preclinical tumor models" (Abstract

#3048, Developmental Therapeutics: Immunotherapy Session) -- Poster

presentation from 2:00 p.m. to 6:00 p.m. loca

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
2. Medarex Announces Ipilimumab Program Continues to Move Forward
3. Medarex to Receive Milestone Payment from Amgen
4. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172
7. XTENT Announces First Quarter 2008 Financial Results
8. Neuralstem Announces Issuance of Core Technology Patent in Europe
9. ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
10. PulmoBioTech Announces Details of Its Regulatory Approval Experiments
11. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
Post Your Comments:
(Date:12/19/2014)... TODAY, AEGATE, the leader in medicine verification ... of Peter Fox as Chief Technology Officer ... Officer. Peter has served as Development Director ... Oracle in 2011. Prior to Datanomic, Peter ... and subsequently Convergys, a world renowned billing system for ...
(Date:12/19/2014)... Pa. , Dec. 19, 2014 You,re ... routine checkup and cleaning when he or she says ... you,ve probably heard before, you may have several questions ... You,ll be relieved to know it,s nothing to worry ... answer patients, questions and alleviate any anxiety the public ...
(Date:12/19/2014)... Dec. 19, 2014 Breckenridge Pharmaceutical, Inc. announced ... with MSN Laboratories Pvt. Ltd. ( Hyderabad, India ... commercialize several new ANDAs.  Under the terms of the ... exclusively to Breckenridge for the U.S. market, and Breckenridge ... Breckenridge and MSN have agreed to develop an oral ...
Breaking Medicine Technology:Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Root Canals Have Become More Routine 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2
(Date:12/21/2014)... (PRWEB) December 21, 2014 Concept Plus, LLC. ... engineering firm headquartered in Fairfax, VA., today announced it ... its Fast 50 list, which ranks the fastest growing government ... from 2009 to 2013. , This is the first year ... it ranked # 20 with a 95.92% compound annual growth ...
(Date:12/20/2014)... (PRWEB) December 21, 2014 ... . Recently, the business has announced its bamboo ... buys the best material from certified suppliers, and ... its customers worldwide. In the current promotion, all ... 20% off, when they say they know ...
(Date:12/20/2014)... has recently announced its new ... promotion of special occasion dresses for the coming new ... special occasion dresses for global women. Now, all the ... up to 80% off. Among the new items, the ... 16 Dress) is very popular. What’s more, also ...
(Date:12/20/2014)... Dress company LunaDress has recently announced its ... Sale, offering big discounts on all of its special occasion ... to own a perfect wedding gown. If you have no ... come to LunaDress. Many different wedding dress styles and our ... now and enjoy the current special offer, up to 80% ...
(Date:12/20/2014)... The print component of Healthy Aging ... of approximately 160,000 copies and an estimated readership of ... vast social media strategy and across a network of ... digital version of the campaign, click here . ... the ladies of CTV’s The Social. Lainey Lui, ...
Breaking Medicine News(10 mins):Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:Eco-friendy Bamboo Flooring Manufacturer Introduces Its Bamboo Flooring Promotion for 2015 2Health News:Tons of New-in Winter Sweet 16 Dresses from Weddingshe Online Now 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:The ladies of The Social urge Canadian women to put themselves first over the holiday season and into the new year in Mediaplanet’s “Women’s Health” campaign 2
... identify patients who need little, if any, immune suppression ... molecule called HLA-G dimer plays a powerful role in ... tissue, Medical College of Georgia researchers say. , ... in mice and are currently studying whether this molecule ...
... is most likely in younger males, study finds , , ... suffering a heart attack, nearly one in five survivors ... almost 2,000 patients. , Researchers found that 389 (19.9 ... one year after hospitalization for heart attack. This included ...
... such an effect from a nutrient, experts say , , MONDAY, ... levels of vitamin D may be at increased risk of dying ... suggests. , Some 50 percent to 60 percent of ... have insufficient levels of vitamin D. The same is true for ...
... Lyon, France - June 23, 2008 - Sanofi ... announced today that the U.S. Food and Drug ... Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and ... vaccine is indicated for active immunization against diphtheria, ...
... June 23 Marketing budgets are usually,among the ... tell,Sally Gilbert., Gilbert is creator of the ... for health-conscious,consumers taking place in Charlotte in early ... spent $9,000 on marketing already and plans to,spend ...
... MADISON, N.J., June 23 Quest Diagnostics,Incorporated (NYSE: ... diagnostic,testing, information and services, announced that it is ... Tuesday, June 24, 2008. The Quest,Diagnostics presentation is ... The presentation will be webcast live during the ...
Cached Medicine News:Health News:Immune Molecule Key to Preventing Organ Rejection 2Health News:Angina Strikes 1 in 5 Heart Attack Survivors 2Health News:Low Vitamin D Could Raise Death Risk 2Health News:Low Vitamin D Could Raise Death Risk 3Health News:US FDA licenses Sanofi Pasteur's new pediatric combination vaccine, pentacel 2Health News:US FDA licenses Sanofi Pasteur's new pediatric combination vaccine, pentacel 3Health News:Maverick Marketers Defy Economic Slowdown 2
... is designed to give accurate and ... neurosurgical intensive care, trauma, and operating ... and easy to use, and provides ... built-in audible alarm alerts attending staff ...
A portable, easy to use, dual-channel laser-Doppler tissue perfusion and temperature monitoring system, at a remarkably affordable price....
... highly featured laser doppler system for ... from multiple tissue sites. This latest ... Signal Processing (DSP) and laser Doppler ... simple to use, multi-channel monitor, setting ...
... highly featured laser doppler system for ... from multiple tissue sites. This latest ... Signal Processing (DSP) and laser Doppler ... simple to use, multi-channel monitor, setting ...
Medicine Products: